| Abstrakt: |
This mini-review describes the rapid changes in genome technologies that are leading to comprehensive views of genetic alterations in cancer, and presents high-level thoughts on ways to accelerate translation into clinical medicine. Issues that are more relevant to children, adolescents, and young adult patients with cancer are highlighted. Cancer 2011;117(10 suppl):2262-7. © 2011 American Cancer Society. Rapid changes in genome technologies are leading to comprehensive views of genetic alterations in early onset cancers, and present new opportunities for clinical translation. In the current study, issues that are more relevant to children, adolescents, and young adult patients with cancer are highlighted. [ABSTRACT FROM AUTHOR] |
Plný text